Globus Medical, Inc. (GMED)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 789 | 958 | 1,023 | 1,568 | 2,519 | 2,939 | 3,145 | 3,199 |
| Operating profit | $m | 480 | 653 | ||||||
| Net profit | $m | 102 | 149 | 190 | 123 | 103 | 538 | 535 | 685 |
| EPS reported | $ | 3.92 | 3.89 | ||||||
| Operating cashflow per share | $ | 5.57 | 6.73 | ||||||
| Capex per share | $ | 1.22 | 1.18 | ||||||
| FCF per share | $ | 4.36 | 5.54 | ||||||
| Free cash flow | $m | 589 | 751 | ||||||
| Net debt | $m | -453 | -595 | ||||||
| Book value equity | $m | 4,573 | 4,769 | ||||||
| Book value per share | $ | 33.33 | 34.51 | ||||||
| Number of shares | m | 137.22 | 138.19 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 22.27 | 19.16 | ||||||
| P/B LTM | x | 2.58 | 2.47 | ||||||
| P/S LTM | x | 4.02 | 3.75 | ||||||
| P/FCF LTM | x | 20.04 | 15.72 | ||||||
| EV/EBITDA LTM | x | 15.61 | 13.00 | ||||||
| EV/Sales LTM | x | 3.88 | 3.56 | ||||||
| Earnings Yield LTM | % | +4.49% | +5.22% | ||||||
| FCF Yield | % | +4.99% | +6.36% | ||||||
| Quality | |||||||||
| ROE | % | +11.76% | +11.59% | ||||||
| ROIC | % | +8.78% | +10.46% | ||||||
| Operating margin | % | +16.33% | +20.75% | ||||||
| Gross margin | % | +67.41% | +68.55% | ||||||
| FCF/Sales | % | +20.03% | +23.87% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +422.67% | +418.67% | ||||||
| Sales Growth YoY | % | +16.65% | +24.83% | ||||||
| Net Income Growth YoY | % | +422.31% | +419.95% | ||||||
| FCF Growth | % | +45.30% | +85.24% | ||||||
| Operating Profit Growth | % | +189.05% | +293.21% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 4.96 | 6.75 | ||||||
| Net Debt/EBITDA | x | -0.56 | -0.45 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +0.88% | 0.00% | ||||||
| Net debt/Equity | x | -0.10 | -0.12 | ||||||
| Gross debt/equity | x | 0.03 | 0.02 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free